However, using FACS analysis to detect GFP+ tumor cells in the xenotransplants on day 24, a high percentage of CD133+ cells were preserved in tumors derived from LPC-H cells expressing shRNA against mTOR (Figure 6A). This evidence concerns the gene MTOR and neoplasm.